Study
CPCT-02
Data & DNA profiles
Whole genome sequencing of tumors, linked to treatment outcomes.
Since 2012 · >40 hospitalsSince 2012 · >40 participating Dutch hospitals
For everyone a personal approach to cancer
At the Center for Personalized Cancer Treatment (CPCT), doctors, researchers and hospitals work together to better understand why an approach works for one person and not for another.
Our mission
Time is precious. Data makes the difference
When you are diagnosed with cancer and a cure is no longer possible, time often becomes extraordinarily precious.
That is why CPCT works together with doctors and researchers to better understand why certain patients respond well to a treatment while others do not. These insights can help put together a personal treatment plan as quickly as possible.
In addition, we want to learn which (apparently) healthy people should be monitored extra closely in order to detect cancer early, when cure is still relatively straightforward.
To make this mission possible, CPCT supports research by leading scientists with bold, fundamentally innovative ideas.
>40
Dutch hospitals
14 yrs
Research & collaboration
>8,000
Patients in the database
3 + 2
National + European studies
>200
Scientific publications
The three pillars of CPCT
From the lab to the hospital to the patient's room, all with one goal: treatment tailored to the individual.
01, Curing cancer
Better prediction of what works
By studying the molecular characteristics of tumors we learn which treatments are most promising for which patients.
About CPCT
02, Studies & research
CPCT-02, DRUP and DAP
Large national studies, run by doctors, nurses and researchers across more than 40 Dutch hospitals.
View studies
03, For researchers
Data and biomaterial
A database with data from more than 8,000 patients and a biobank with material available for follow-up scientific research.
For researchersPodcast
DRUP in Nature: podcast on the first 1,610 treated patients
In a recent Nature publication, researchers report on the first 1,610 patients treated within the DRUP study. The accompanying podcast discusses the findings and what they mean for precision medicine.
Read the article on Nature.comStudies
Explore all studiesNational studies with worldwide impact
From collecting data to treating patients, each plays a distinct role in precision medicine.
Study
DRUP
Treatment on demand
Targeted drugs based on the molecular characteristics of the tumor.
Study
PRIME-ROSE
DRUP across Europe
Ten European countries scaling DRUP for broader access.
Study
DAP
Faster access
Accelerated access to new targeted drugs pending reimbursement.
Study
BEACON
Precision prevention
Unravelling the non-coding part of our DNA (The Dark Genome) to better predict cancer risk.
For researchers
A database of >8,000 patients for scientific research
Clinical data, whole genome sequencing and biological material available for follow-up research that improves cancer treatment.
Procedure & requests
FAQ
Patient questions
From consent and privacy to what happens with your material and data.
All frequently asked questions Participating hospitals
View all locationsMore than 40 hospitals across the Netherlands
Patients can participate through their own oncologist at one of the affiliated centers.
Amphia ZiekenhuisAmsterdam UMCBernhovenBravisCatharina ZiekenhuisDeventer ZiekenhuisElisabeth-TweeSteden ZiekenhuisElkerliekErasmus MCFranciscus Gasthuis & VlietlandFrisius MCGelderse ValleiGelre ZiekenhuizenHaaglanden MCHagaZiekenhuisIsala
“Cancer care must improve radically. That requires scientific research based on bold ideas.”
Stichting CPCT
Support the research
Help make this research possible
CPCT research is made possible thanks to donations via Stichting Stelvio for Life (ANBI). Every donation goes in full to CPCT.